Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis

Open Access

Peer-reviewed

Research Article

Samiul Hasan,

Affiliation Novartis Institute for Tropical Diseases (NITD), Chromos, Singapore
⨯
Sabine Daugelat,

Affiliation Novartis Institute for Tropical Diseases (NITD), Chromos, Singapore
⨯
P. S. Srinivasa Rao,

Affiliation Novartis Institute for Tropical Diseases (NITD), Chromos, Singapore
⨯
Mark Schreiber

*To whom correspondence should be addressed. E-mail: mark.schreiber@novartis.com

Affiliation Novartis Institute for Tropical Diseases (NITD), Chromos, Singapore
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Drug metabolism
Is the Subject Area "Drug metabolism" applicable to this article?

Thanks for your feedback.
Protein domains
Is the Subject Area "Protein domains" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Tuberculosis drug discovery
Is the Subject Area "Tuberculosis drug discovery" applicable to this article?

Thanks for your feedback.